trial · primary record
GSK5471713
Neoplasms, Prostate
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 54 |
| Primary completion | 2030-03-26 |
| Primary endpoint | Number of participants with dose limiting toxicities (DLTs) |
| Registry ID | NCT07332455 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:26.862Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07332455
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.